a KA (Kaletra 200 mg / 50 mg)

Generic Name: lopinavir/ritonavir

Pill with imprint a KA is Yellow, Elliptical / Oval and has been identified as Kaletra 200 mg / 50 mg. It is supplied by Abbott Laboratories.

Kaletra is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Kaletra 200 mg / 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for a KA

Kaletra

Generic Name:

lopinavir/ritonavir

Imprint:

a KA

Strength:

200 mg / 50 mg

Color:

Yellow

Size:

19.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Protease inhibitors

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Abbott Laboratories

Inactive Ingredients:

sorbitan monolaurate
silicon dioxide colloidal
sodium stearyl fumarate
titanium dioxide
polyethylene glycol 400
hydroxypropyl cellulose
magnesium silicate
polyethylene glycol 3350
ferric oxide yellow
polysorbate 80
hypromelloses
copovidone
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
54569-5752	A-S Medication Solutions, LLC (repackager)
54868-5566	Physicians Total Care Inc. (repackager)
55289-0947	PDRX Pharmaceuticals Inc. (repackager)
35356-0112	Lake Erie Medical and Surgical Supply (repackager)
68071-0748	Nucare Pharmaceuticals Inc. (repackager)

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.